<SEC-DOCUMENT>0000950103-25-003139.txt : 20250307
<SEC-HEADER>0000950103-25-003139.hdr.sgml : 20250307
<ACCEPTANCE-DATETIME>20250307080216
ACCESSION NUMBER:		0000950103-25-003139
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250306
FILED AS OF DATE:		20250307
DATE AS OF CHANGE:		20250307

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AUNA S.A.
		CENTRAL INDEX KEY:			0001799207
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41982
		FILM NUMBER:		25717613

	BUSINESS ADDRESS:	
		STREET 1:		6, RUE JEAN MONNET
		CITY:			GRAND DUCHY OF LUXEMBOURG
		STATE:			N4
		ZIP:			L-2180
		BUSINESS PHONE:		51 (205-3500)

	MAIL ADDRESS:	
		STREET 1:		6, RUE JEAN MONNET
		CITY:			GRAND DUCHY OF LUXEMBOURG
		STATE:			N4
		ZIP:			L-2180

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AUNA S.A.A.
		DATE OF NAME CHANGE:	20200930

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AUNA S.A.
		DATE OF NAME CHANGE:	20200108
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>dp225993_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B>&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.85pt; text-align: center; text-indent: -6.85pt"><B>REPORT OF FOREIGN
PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.85pt; text-align: center; text-indent: -6.85pt">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the month of March 2025</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Commission File
Number: 001</B></FONT>-<FONT STYLE="font-size: 14pt"><B>41982</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 22pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Auna S.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact name of registrant as specified in its
charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&lrm; 6, rue Jean Monnet</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>L-2180 Luxembourg</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Grand Duchy of Luxembourg</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&lrm;+51 1-205-3500&lrm;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Address of principal executive office)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Indicate by check mark whether the registrant files
or will file annual reports under cover of Form&nbsp;20-F or Form 40-F:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 31%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Form 20-F</FONT></TD>
    <TD STYLE="width: 13%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 0.5pt solid">X</P></TD>
    <TD STYLE="width: 15%; font-size: 12pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 28%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt">Form 40-F</FONT></TD>
    <TD STYLE="width: 13%; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; font-size: 12pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>EXHIBIT</B></FONT></TD>
    <TD STYLE="width: 90%; font-size: 12pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt; text-align: center"><A HREF="dp225993_ex9901.htm" STYLE="color: Blue; text-decoration: underline"><FONT STYLE="font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="font-size: 12pt"><A HREF="dp225993_ex9901.htm" STYLE="color: Blue; text-decoration: underline"><FONT STYLE="font-size: 10pt">Press release dated March 7, 2025 &ndash; Auna Signs Exclusive Five-Year Agreement with Leading Oncology Group to Strengthen Oncology Services in Monterrey</FONT></A></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>Auna S.A.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Gisele Remy </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 27%">&nbsp;</TD>
    <TD STYLE="width: 21%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 33%"><FONT STYLE="font-size: 10pt">Gisele Remy</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: March 7, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dp225993_ex9901.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="image_001.jpg" ALT="A blue and green logo&#10;&#10;Description automatically generated" STYLE="height: 67px; width: 221px"></FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Auna Signs Exclusive
Five-Year Agreement with Leading Oncology Group to Strengthen Oncology Services in Monterrey</B></FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Monterrey, Mexico,
March, 07, 2025 &ndash; Auna S.A.&nbsp;&nbsp;(NYSE: AUNA)</B> (&ldquo;Auna&rdquo; or the &ldquo;Company&rdquo;), a Latin American healthcare
company with operations in Mexico, Peru, and Colombia, announced today the signing of an exclusive five-year agreement with a physician
group practicing at Organizaci&oacute;n Para Cuidado Integral en Oncolog&iacute;a, S.A. de C.V. known as Opci&oacute;n Oncolog&iacute;a,
the premier oncology ambulatory clinic in Monterrey. This strategic partnership strengthens Auna&rsquo;s commitment to becoming the leading
oncology provider in Mexico and marks a significant step in consolidating oncology services within Auna Mexico.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">As part of this
agreement, eight highly regarded physicians &ndash; six oncologists and two radiation oncologists &ndash; will join Auna. Today, their
practice manages approximately 30% of all private oncology treatments in Monterrey, referring patients to multiple facilities across
the city. Through this partnership, Auna will integrate 100% of these treatments within its network over time, strengthening care coordination
and enhancing the patient experience.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">The team will relocate
to Doctors Hospital, further strengthening Auna&rsquo;s oncology capabilities. This move will position Auna&rsquo;s Oncology Center as
one of the few multidisciplinary and fully integrated oncology centers operating in Mexico&rsquo;s private healthcare market. Among the
distinguished doctors joining Auna are Dr. C&eacute;sar Gonz&aacute;lez de Le&oacute;n and Dr. Cuauht&eacute;moc De la Pe&ntilde;a Hinojosa,
both recognized as leading oncologists in Mexico and widely referenced in their field. Dr. Gonz&aacute;lez will play a key leadership
role on Auna&rsquo;s Oncology Board, serving as Chair of Medical Oncology and Co-Chair of the practice for Auna&rsquo;s Center of Excellence
in Oncology in Mexico. Dr. De la Pe&ntilde;a Hinojosa will lead Radiation Oncology as Chair of Radiation Oncology on Auna Mexico&rsquo;s
Oncology Board.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">This partnership
strengthens Auna&rsquo;s ongoing expansion and Auna&rsquo;s commitment to delivering world-class oncology care. It follows the successful
launch of OncoMexico last year and aligns with the upcoming inauguration of Auna&rsquo;s Oncology Research Center in Mexico. This new
research facility will collaborate with Auna&rsquo;s existing research centers in Peru and Colombia, driving clinical research and advancing
cancer treatment throughout the region.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;This agreement
is an important step for Auna in Mexico to continue implementing the AunaWay,&rdquo; said Suso Zamora, Executive Chairman and President
of Auna. &ldquo;By bringing together some of the country&rsquo;s most respected oncology experts and consolidating our oncology services,
we are reinforcing our mission to provide the highest quality cancer care. With this partnership, Auna is poised to become the leading
oncology provider in Monterrey.&rdquo;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Dr. Gonz&aacute;lez
de Le&oacute;n and Dr. De la Pe&ntilde;a Hinojosa added, &ldquo;We are thrilled as a team to join Auna&rsquo;s mission to elevate oncology
care in Mexico. This collaboration allows us to enhance patient care, drive research, and set new standards in oncology treatment by
partnering with the best in the industry.&rdquo;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>About Auna</B></FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #303132"><FONT STYLE="font-size: 10pt">Auna
is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia,
focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering
in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America&prime;s largest modern
healthcare platforms that consists of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio
of oncological plans and selected general healthcare plans. As of September 30, 2024, Auna&rsquo;s network included 31 healthcare network
facilities, including hospitals, outpatient, prevention and wellness facilities with 2,308 beds, and 1.3 million healthcare plans.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #303132"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #303132"><FONT STYLE="font-size: 10pt">This
press release contains forward-looking statements. Forward-looking statements convey our current expectations or forecasts of future
events. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance
or achievements to differ materially from the forward-looking statements that we make. Forward-looking statements typically are identified
by words or phrases such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;aim,&rdquo;
&rdquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;project,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;potential,&rdquo;
&ldquo;continue,&rdquo; &ldquo;is/are likely to,&rdquo; or other similar expressions. Forward-looking statements that appear in a number
of places in this press release include, but are not limited to, statements regarding the intent, belief or current expectations, regarding
various matters, including, the expected impact of our agreement with a physician group practicing at Opci&oacute;n Oncolog&iacute;a
and our integration of their practice into Auna. Any or all of our forward-looking statements in this press release may turn out to be
inaccurate. Our actual results could differ materially from those contained in forward-looking statements due to a number of factors.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #303132"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #303132"><FONT STYLE="font-size: 10pt">The
forward-looking statements in this press release represent our expectations and forecasts as of the date of this press release. Except
as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new
information, future events or otherwise, after the date of this press release. For a discussion of the risks facing the Company which
could affect whether these forward-looking statements are realized, see our Form F-1 filing with the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #303132"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 10pt; color: #303132">For
more information visit&nbsp;</FONT><FONT STYLE="font-size: 10pt; color: #467886">www.aunainvestors.com</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Investor Relations Contact</B></FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt; color: #467886; background-color: white">contact@aunainvestors.com</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !# -T# 2(  A$! Q$!_\0
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M@R >E8G_  D5U_SSA_(_XUYF*S&AA9*%1ZO4[%%LZ.BN<7Q#<E@/+AY/H?\
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M[6/,>1C<*\+5Y+W70[KX??\ 'C>?]=1_*NNKD?A]_P >-Y_UU'\JZZO,Q/\
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D !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
